So-Young's Aesthetic Center Engine: Accelerating Scale, Turning the Corner to Profitability

Q1 2026 revenue up 46% as clinic chain drives 186% surge in treatment revenue; 59 centers now operating and blockbuster products hit 41% of revenue.

SY · Earnings Call · 2026-05-22

The Pivot Is Complete: So-Young Is Now a Clinic Chain

The first quarter marks a definitive turn: So-Young International (SY) has transformed from a medical aesthetic platform into an operating clinic chain. Aesthetic center revenue grew 185.8% year-over-year to RMB 282 million, now representing over 65% of total revenue. CEO Xing Jin noted, “In Q1, total revenue reached RMB 433 million, up around 46% year-over-year. Revenue from our aesthetic center business reached RMB 282 million, up around 186% year-over-year.” — Mona Qiao, Host / Interpreter · 2026-05-22 The financials are equally telling: total revenue rose 45.6% to RMB 432.8 million, with the aesthetic treatment service segment hitting the high end of guidance for the fourth consecutive quarter. The company's network has grown to 59 centers across 17 cities as of the call date (a net add of 10 since year-end 2025), with an aggressive push into Tier 1 cities. This scale is now yielding operational leverage: 41 centers are profitable and 48 generated positive operating cash flow in Q1.

Profitability: The Next Frontier

While the company remains loss-making (net loss attributable to So-Young was RMB 49.2 million in Q1), management is signaling a clear path to profitability. Gross margin for the aesthetic center business improved to 27%, reflecting a 8.4 percentage point year-over-year expansion. The blockbuster product strategy is working: blockbuster products accounted for 41% of revenue, driven by high-demand treatments like BBL and thermage. The company is also diversifying its supply chain through partnerships and proprietary products, including the launch of Miracle Collagen with Jinbo Biopharmaceutical.

We aim to create value for users and shareholders and to drive industry's long-term development.
Mona Qiao, Host / Interpreter · 2026-05-22

As the dual-engine of scale and efficiency initiative matures, management expects Q2 aesthetic treatment revenue to grow 112.6% to 119.5% year-over-year, a deceleration from Q1's 185.8% but still robust.

The Competitive Moat: Standardization and Medical Excellence

The company's differentiation lies in its standardized, "fast casual" model for light medical aesthetics, a departure from traditional high-touch, high-cost centers. “Our aesthetic center business is fundamentally different from traditional model by the likes of Mylike and Yestar. In short, this institution is by dialing operational model.” — Xing Jin, Co-Founder, Chairman and CEO · 2025-05-16 So-Young invests heavily in training and R&D—establishing a physician training center and a control center to ensure consistent quality across the network. This focus on Medical Aesthetics excellence is underpinned by a supply chain business that enhances cost competitiveness and product exclusivity. Prior calls have emphasized the compliance framework: “We have built a six-pillar compliance framework covering compliance, risk control, supervision, internal audit, medical service delivery, and information security departments.” — Mona Qiao, Management · 2025-11-17 This is now being institutionalized as the network scales.

Why It Matters

So-Young is at an inflection point. The rapid expansion is now being matched by improving unit economics. The market is rewarding companies that can demonstrate sustainable growth with a clear path to profitability. With the aesthetic center business now the core engine and 1,000 centers in the long-term target, the company is positioning itself as the leading chain in China's light medical aesthetic sector. The next few quarters will be critical to see if the scaling can translate into net income. But there are risks: competition from both traditional institutions and new entrants, and the company's net loss persists. The company's ability to maintain growth while improving margins will be the key over the next year.